Drug intelligence / Profile preview

codeine + diclofenac

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Rectal, Intramuscular
01

Overview

Codeine + diclofenac is a combination analgesic drug consisting of codeine, an opioid analgesic, and diclofenac, a nonsteroidal anti-inflammatory drug (NSAID). This combination is used for the management of moderate to severe pain where both inflammatory and nociceptive components are present. Codeine acts primarily as a prodrug that is metabolized to morphine in the body, exerting its effect by agonizing mu-opioid receptors in the central nervous system to reduce pain perception and induce sedation[5][8]. Diclofenac inhibits cyclooxygenase (COX)-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins involved in inflammation and pain signaling[3]. The combination may provide superior analgesia compared with either agent alone but can increase the risk of side effects such as gastrointestinal irritation (from diclofenac) or respiratory depression (from codeine)[1][5].

Other names
codeine and diclofenacdiclofenac and codeinediclofenac + codeine
02

Targets

DOR (Opioid Receptor Delta 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on codeine + diclofenac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on codeine + diclofenac.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call